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Abstract
The catalytic loop HRD motif is found in most protein kinases and these amino acids are predicted to perform functions in
catalysis, transition to, and stabilization of the active conformation of the kinase domain. We have identified mutations in a
Drosophila src gene, src64, that alter the three HRD amino acids. We have analyzed the mutants for both biochemical
activity and biological function during development. Mutation of the aspartate to asparagine eliminates biological function
in cytoskeletal processes and severely reduces fertility, supporting the amino acid’s critical role in enzymatic activity. The
arginine to cysteine mutation has little to no effect on kinase activity or cytoskeletal reorganization, suggesting that the
HRD arginine may not be critical for coordinating phosphotyrosine in the active conformation. The histidine to leucine
mutant retains some kinase activity and biological function, suggesting that this amino acid may have a biochemical
function in the active kinase that is independent of its side chain hydrogen bonding interactions in the active site. We also
describe the phenotypic effects of other mutations in the SH2 and tyrosine kinase domains of src64, and we compare them
to the phenotypic effects of the src64 null allele.
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Introduction
Src is a member of the Src Family Kinases (SFKs), a group of
nonreceptor tyrosine kinases that share a common structure
consisting of an N-terminal myristoylation site, an SH3 domain,
an SH2 domain, a tyrosine kinase domain and a C-terminal
negative regulatory domain. Myristoylation of the SFK protein
tethers it to the inner face of the plasma membrane, whereas the
SH3 and SH2 domains mediate interactions with proline-rich
recognition sequences and phosphotyrosine-containing sequences,
respectively [1,2]. Intramolecular interactions between the SH2
and SH3 domains and their recognition sites in the SFK hold the
protein in a closed, inactive conformation. Release of these
intramolecular interactions by dephosphorylation of the C-
terminus or by SH2 binding of another phosphotyrosine protein
leads to the adoption of an open, partially active conformation.
Phosphorylation of the activation loop leads to the adoption of the
fully active conformation. The SFK active site is located in a cleft
between the N-terminal lobe and the C-terminal lobe of the kinase
domain, where substrate, ATP and Mg
++ cations bind. Two
critical elements of the active site are the DFG motif-containing
activation loop and the HRD motif-containing catalytic loop [3].
The HRD amino acids are thought to be involved in the reaction
mechanism or the formation and stabilization of the active site
[4–6].
SFKs have been shown to be involved in regulating the actin-
based microfilament cytoskeleton [1,7]. The Drosophila genome
contains two genes that encode SFKs: src42 and src64 [8]. Both act
in the remodeling of the microfilament cytoskeleton during dorsal
closure [9,10]. However, in ring canal growth in the egg chamber,
src64 seems to function independently of src42 [9]. Ring canals are
intercellular bridges linking the nurse cells to the developing
oocyte, formed from the actin-rich arrested cleavage furrow that
remains after incomplete cell division [11]. Src64 is required for
ring canal growth [12–17].
src64 is also required for microfilament contraction during the
formation of the cellular blastoderm [18]. During early Drosophila
embryogenesis, synchronized nuclear division proceeds without
concomitant cell division. After nuclear division stops, a single
layer of cells is formed by the simultaneous and uniform
invagination of plasma membrane between the peripheral nuclei
[19]. The leading edge of membrane invagination, the cellulariza-
tion front, consists of stable infoldings of membrane called furrow
canals surrounded by microfilaments [20–25]. Contractile tension
in the microfilament network maintains uniform invagination of
furrow canals during early cellularization, and constriction of
microfilament rings partly closes cell bases during late cellulariza-
tion [18,26]. However, contraction of the microfilament network is
not required for membrane invagination [18,26]. src64 mutant
defects in both microfilament ring contraction and ring canal
expansion are easily quantified, providing sensitive and effective
means of assaying the biological function of src64 [12,18].
To understand the role of src64 in regulating microfilament ring
contraction during cellularization, we identified point mutations in
the src64 coding region. Of particular interest were mutations in
each of the three highly conserved amino acids that constitute the
HRD motif of the kinase domain catalytic loop. We analyzed the
phenotypes caused by the mutation in the catalytic aspartate and
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e28100the src64 null allele and found that Src64 kinase activity is required
for microfilament ring contraction. We also found that mutations
in the histidine and arginine residues produced weaker cytoskeletal
defects and lower reductions of kinase activity than expected. We
discuss the implications of these results on the roles of the HRD
amino acids in kinase domain activity and activation.
Materials and Methods
Genetics
Flies were cultured on a standard medium at 22.5u. Embryos
were collected from yeasted apple juice/agar plates at 22.5u and
counted during days three to ten. After forty hours, hatched and
unhatched eggs were counted. OreR was used as the wild-type
strain. src64
D17 and src64
KO have been described [12,14,18]. Other
alleles are described in Flybase [8]. src64 point mutations were
identified by mismatch between the wild-type sequence between
primers in exon five (atcgacgacaccgagtccgattg) and exon eight
(cgacgtgaccgagaaggactcgaagt) and the Zuker EMS-mutagenized
lines [27] by the Seattle Targeting Induced Localized Lesions in
Genomes (TILLING) Project [28]. The mutations consisted of one
mutation in an intron, eight silent mutations, ten unique missense
mutations, a duplicate of one of the missense mutations and two
additional missense mutations that were no longer available.
Potential background mutations were reduced by generating th st
cu sr e
s ca recombinants. src64
D17, src64
KO and src64
+ were th st cu sr
e
s ca. src64
S440F recombinants were st cu sr e
s ca, and src64
D372N and
src64
H402L recombinants were ht hs tc us re
s ca. Alleles were
confirmed by PCR, polymorphism or direct sequencing.
Immunohistochemistry and image analysis
Embryos were methanol heat-fixed [29] and stained with rabbit
anti-myosin II heavy chain antibody (1:1000) [30]. Ovaries were
dissected and fixed in 4% paraformaldehyde [31] and stained with
either anti-HTS antibody (1:1) [11] (Developmental Studies
Hybridoma Bank) or Alexafluor 488-conjugated phalloidin
(Invitrogen) and Hoechst. Specimens were imaged using an
Axioimager.A1 fluorescence microscope (Zeiss) or a Fluoview 300
confocal microscope (Olympus). Images were analyzed using
Axiovision 4.4 (Zeiss) and ImageJ (W. Rasband, NIH; http://rsb.
info.nih.gov/ij/). Outer diameters of all ring canals were measured
in stage 10A egg chambers [12]. 4–14 egg chambers were
compared using Kruskal-Wallis/Dunn’s test. For amorph tests, the
Wilcoxon-Mann-Whitney test was used, and 5–6 egg chambers for
heterozygotes, and 11–19 egg chambers for homozygotes and
trans-heterozygotes were analyzed. Cellularization microfilament
rings from the embryo midsection were measured and circularity
(4pA/p
2 where A=area, and p=perimeter) calculated [18]. 10
rings from each of 3–6 embryos were compared using one-way
ANOVA/Tukey-Kramer test. For amorph tests, the Wilcoxon-
Mann-Whitney test was used on 25 rings from each of 5–10
embryos.
Kinase assays
Homozygous src64 mutant embryos from homozygous src64
mutant parents were collected in a mesh basket and dechorionated
in 50% bleach for two minutes [29] and washed in phosphate-
buffered saline pH 6.5/0.1% Tween 20. Cellularizing embryos
were selected by hand under the stereoscopic microscope,
disrupted using a melted micropipette tip as a pestle in hypotonic
lysis buffer [32] with 50% glycerol, and centrifuged at 16,000x g
for 30 min at 4u. Supernatants were stored at 220u. Kinase assays
were conducted on 0.58 mg to 1.80 mg of total protein using the
SignaTECT protein tyrosine kinase assay system (Promega).
Reactions proceeded in the presence of c-
32P-labeled ATP and
sodium vanadate for 15 minutes at 30u. Phosphotransfer to the
manufacturer’s peptide substrate 2 was measured by liquid
scintillation counting, and did not differ by cellularization stage.
Src64-dependent tyrosine kinase activity was determined by
subtracting measured total tyrosine phosphotransfer in src64
KO
mutant embryo extracts (7.97 pmol/min/mg) from measured total
tyrosine phosphotransfer in the other samples. Five independent
extracts were assayed from each genotype. src64
KO and src64
D404N
extracts were generated by pooling supernatants from multiple
embryo collections because of the extremely low numbers of
embryos produced by these genotypes. Kinase assays were
conducted in triplicate. Kinase activity was compared to wild
type using ANOVA/Dunnett test.
Results
Identification of missense mutations in src64
To identify mutations that alter the coding sequence of src64 in
a phenotypically unbiased manner, mutants were screened using
the Targeting Induced Localized Lesions in Genomes (TILLING)
procedure [27,28]. Ten missense mutations were identified: five in
the SH2 domain and five in the tyrosine kinase domain (Table 1).
Fertility and Embryonic Viability Defects
Most of the src64 mutants can be maintained as homozygous
lines. Neither the null allele src64
KO [14] nor the src64
D404N allele is
viable as a homozygous line; however, heterozygous parents
produce homozygous progeny that produce homozygous embryos
that live past gastrulation. The nuclear defect in src64
D17 mutant
embryos [18] was not observed in other src64 mutants, suggesting
that it is not caused by src64 mutation.
Src64 protein is not expressed in the male reproductive system,
and src64
KO mutants have no defects in spermatogenesis or male
fertility (A. O’Reilly, personal communication). However, src64
D17
and src64
KO mutant females show fertility defects: reduced number
of eggs laid and reduced proportion of eggs that hatch [12,14]. We
characterized female fertility defects by crossing wild-type males to
females trans-heterozygous for src64 mutations and src64
KO to
minimize potential fertility defects caused by background muta-
tions, and scoring egg yield and hatch rate during the most robust
period of egg production. Most, if not all, of the src64 mutations
caused lower egg yields (Table 1). The src64
D17, src64
KO and
src64
D404N mutations produced substantially lower egg yields than
the wild-type allele (Table 1). Overall relative fecundity of mutant
alleles is lower than indicated because egg laying drops off sooner
in most mutants than in wild type. Fertility defects in src64 mutant
females are not caused by defects in the germline stem cells.
Activated Src64 protein is not observed in either the germline stem
cells or the somatic cells of the stem cell niche [14].
Maternal viability defects were milder than egg production
defects. None were observed for src64
P190L, src64
G208E, src64
R217C,
src64
D372N, src64
R403C and src64
S440F. The higher hatch rate of eggs
laid by src64
S440F/src64
KO trans-heterozygous females was likely
caused by heterozygosity for th. src64
KO and src64
D404N mutations
caused severely reduced hatch rates (Table 1). None of the females
trans-heterozygous for src64
KO showed an egg laying
or hatching defect as severe as that of src64
KO homozygous
females, suggesting that these mutations are reduction-of-function
mutations.
Ring canal growth defects
src64 is required for the growth of the cytoskeletal ovarian ring
canals in the Drosophila egg chamber [12–14]. We observed ring
Src64 HRD Mutants
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src64 mutants; only src64
P190L, src64
C259Y, src64
R403C and src64
S440F
were indistinguishable from wild type (Fig. 1). Ring canal sizes
varied among the other src64 mutants. Ring canal diameters of
src64
D204V, src64
G208E, src64
R217C, src64
D372 and src64
H420L mutant
egg chambers were significantly smaller than those of wild-type
egg chambers (Fig. 1). src64
D17, src64
D404N and src64
KO mutants
had smaller ring canals than any of the mutants described above.
The ring canal diameters of these mutants were indistinguishable
(Fig. 1).
src64 is also required for ring canal attachment to the nurse cell
plasma membrane [12]. src64
D17 and src64
KO mutants often have
ring canal attachment defects and nurse cell fusion defects [12,14].
src64
D404N mutants have severe nurse cell fusion defects similar to
those of src64
KO mutants (Fig. 2). src64
H402L mutants have nurse
cell fusion defects that occur less frequently than those in src64
D17
mutants (Fig. 2). No nurse cell fusions were observed in src64
R403C
mutant egg chambers (Fig. 2). Detached and prematurely
degenerating ring canals are sometimes observed in src64 mutants
[12]. We also occasionally observed degenerating ring canals in
the egg chambers of strong src64 mutants.
Cellularization microfilament ring contraction defects
src64 is required for microfilament contraction during cellular-
ization [18]. During early cellularization, microfilament rings are
linked together, creating tension in the network through
microfilament contraction [18]. We analyzed src64 mutant
embryos that are both maternally and zygotically mutant:
homozygous for the src64 mutation and derived from mothers
homozygous for the src64 mutation. Furrow canals do not
invaginate uniformly during early cellularization in src64
D17
mutant embryos; variations in the depth of the furrow canals lead
to the appearance of a wavy cellularization front (Fig. 3A) [18].
src64
H402L, src64
D404N and src64
KO mutant embryos show this
phenotype (Fig. 3A), as do src64
R217C and src64
D372N mutant
embryos. The cellularization front defects of src64
R217C, src64
D372N
and src64
H402L mutant embryos were weak and incompletely
penetrant, similar to src64
D17 mutant embryos (Fig. 3A). The
defect was severe in both src64
D404N and src64
KO mutant embryos
(Fig. 3A). None of the mutants showed temperature-sensitive
defects.
To assay microfilament ring contraction defects, we deter-
mined the circularity index, a normalized ratio of area to
perimeter. Deviation from circularity suggests a reduction of
contractile tension in the microfilament ring [18]. Most of the
src64 mutations do not cause microfilament ring defects during
early cellularization. Although some src64
R217C, src64
D372N and
src64
H402L mutant embryos have early cellularization front
defects, they do not have microfilament ring circularity defects
(Fig. 3B, D). The microfilament ring circularity defects of
src64
D404N and src64
KO mutant embryos are indistinguishable,
and significantly more severe than that of src64
D17 mutant
embryos (Fig. 3B, D).
During late cellularization, microfilament rings constrict
[18,20]. Microfilament rings in src64
G208E, src64
R217C, src64
D372N
and src64
H402L mutant embryos show little constriction, similar to
that observed in src64
D17 mutant embryos, and differ in circularity
from wild-type embryos (Fig. 3C, E). The microfilament rings of
src64
KO and src64
D404N mutant embryos do not noticeably constrict
and have more severe circularity defects than src64
D17 mutant
embryos (Fig. 3C, E).
Catalytic loop HRD mutations reduce or eliminate Src64
kinase activity
Three mutations, src64
H402L, src64
R403C and src64
D404N, alter the
three conserved amino acids of the catalytic loop HRD motif. To
analyze the biochemical effects of these mutations, we conducted
kinase assays on extracts from cellularizing embryos. Extracts from
wild-type embryos and src64
KO mutant embryos were used as
controls for full tyrosine kinase activity and Src64-independent
activity, respectively. The majority of tyrosine phosphotransfer to
the peptide substrate is Src64-dependent. Much of the Src64-
independent phosphotransfer is likely due to the activity of Src42,
an SFK present during cellularization but primarily localized to a
Table 1. src64 mutations and fertility of src64
KO trans-heterozygous females.
Allele Mutation
a Substitution
b Domain Eggs laid/female Eggs hatched (%)
+ - - - 498 (n=4) 84% (n=1992)
src64
D17 59 deletion [12] - - 120 (n=9) 43% (n=1017)
src64
KO Knockout [14] - - 13 (n=17) 15% (n=208)
src64
P190L CCTRCTT P190L SH2 216 (n=9) 86% (n=1853)
src64
D204V GATRGTT D204V SH2 379 (n=5) 74% (n=1812)
src64
G208E GGARGAA G208E SH2 390 (n=5) 84% (n=1905)
src64
R217C CGTRTGT R217C SH2 411 (n=8) 87% (n=2794)
src64
C259Y TGCRTAC C259Y SH2 322 (n=8) 67% (n=2124)
src64
D372N GATRAAT D372N kinase 428 (n=5) 87% (n=2138)
src64
H402L CATRCTT H402L kinase 323 (n=6) 73% (n=1796)
src64
R403C CGCRTGC R403C kinase 332 (n=5) 88% (n=1659)
src64
D404N GATRAAT D404N kinase 93 (n=10) 28% (n=850)
src64
S440F TCCRTTC S440F kinase 412 (n=9) 96% (n=2042)
Mutation is shown for each allele. + indicates the wild-type allele. For point mutations, the base pair change, the amino acid substitution and the protein domain
containing the substitution are shown. Female fertility was assayed in females trans-heterozygous for the mutation and the src64
KO allele. Number of eggs laid by
females over days 3–10 after introduction of males, is shown.
aAltered nucleotide is underlined.
bWild-type amino acid is indicated, followed by position and mutant amino acid.
doi:10.1371/journal.pone.0028100.t001
Src64 HRD Mutants
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tyrosine phosphotransfer is likely to be directly catalyzed by
Src64, but may include phosphotransfer from any other tyrosine
kinases activated by Src64.
We compared the Src64-dependent tyrosine kinase activities of
the HRD mutants to those of the controls. src64
H402L, src64
R403C
and src64
D404N mutant embryo extracts had 27%, 90% and 12%
of wild-type activity, respectively (Fig. 4). Tyrosine kinase activity
of the mutant Src64
R403C protein is indistinguishable from that of
the wild-type Src64 protein (Fig. 4). This is consistent with the
wild-type cellularization front and microfilament contraction
phenotypes observed in src64
R403C mutant embryos (Fig. 3).
Tyrosine kinase activity of the mutant Src64
D404N protein is
indistinguishable from Src64-independent activity (Fig. 4). This is
consistent with the observation that the src64
D404N cellularization
phenotypes are indistinguishable from those of src64
KO (Fig. 3).
The Src64
H402L mutant protein shows intermediate tyrosine
kinase activity (Fig. 4), consistent with the weak to moderate
phenotypes observed in src64
H402L mutant embryos during
cellularization (Fig. 3).
src64
D404N is a loss-of-function mutation for ring canal
growth and microfilament contraction
Since src64
D404N mutants show strong defects in the egg
chamber and in cellularizing embryos, we tested whether
src64
D404N is a loss-of-function allele for these cytoskeletal processes
by conducting trans-heterozygote tests using the src64
KO allele to
eliminate src64 function. The diameters of ring canals from
src64
D404N/+ females and src64
KO/+ females were indistinguishable
(Fig. 5A, D) and were similar to those of wild-type homozygotes
(Fig. 1), indicating that src64
D404N is a recessive allele. No
significant differences were observed between ring canal diameters
from src64
D404N/src64
KO trans-heterozygous, src64
D404N and src64
KO
egg chambers (Fig. 5A, D). These results suggest that src64
D404N
acts as a loss-of-function allele for ovarian ring canal growth.
We also tested the src64
D404N allele during early cellularization.
src64 is maternally required for microfilament ring contraction
during cellularization [33]. Maternally mutant embryos were
constructed by crossing wild-type males to females of genotypes
src64
D404N/src64
KO, src64
D404N and src64
KO. The cellularization
front defect of the src64
D404N/src64
KO trans-heterozygous embryos
was similar to those of the homozygous embryos (Fig. 5B). The
circularity defects were indistinguishable (Fig. 5C, E), suggesting
that src64
D404N acts as a loss-of-function allele for microfilament
ring contraction during cellularization.
Discussion
src64
D404N mutation
The catalytic loop aspartate at position 404 in Src64 (chicken c-
Src D386) has a critical role in catalysis [3,5]. It has been proposed
to act as a catalytic base, deprotonating the tyrosine hydroxyl to
Figure 1. Ring canal growth defects in src64 mutant egg
chambers. Ring canals are stained with antibody to HTS. (A) Egg
chambers. Ring canal diameters are reduced in the src64
D17, src64
H402L,
src64
D404N and src64
KO mutants. Scale bar, 50 mm. (B) Typical ring canals
ordered mean by diameter and oriented so diameter is presented along
the vertical axis. Scale bar, 10 mm. (C) Ring canal diameters. A, does not
differ from +; B, differs from + (P,0.05), but not other A alleles, except
src64
D204V differs from src64
R403C (P,0.05); C, differs from + (P,0.001)
and from A alleles (P,0.05) except src64
P190L, but not from group B,
except src64
D372N differs from src64
H402L (P,0.01); D, does not differ
from src64
KO, but differs from all other alleles (P,0.001). Error bars are
SEM.
doi:10.1371/journal.pone.0028100.g001
Figure 2. Nurse cell fusion defects in src64 mutant egg
chambers. Egg chambers are stained with phalloidin (green) and
Hoechst (blue). Partial confocal projections are shown. Nurse cell fusion
(arrows) occurs in src64
D17, src64
H402L, src64
D404N and src64
KO mutants.
Nurse cell fusion does not occur in src64
R403C mutants. Scale bar, 50 mm.
doi:10.1371/journal.pone.0028100.g002
Src64 HRD Mutants
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part of the phosphoryl transfer reaction. However, many studies
suggest that the neutral hydroxyl group acts as the nucleophile.
Aspartate hydrogen bonds, directly or indirectly, to the hydroxyl
group to position it for effective nucleophilic attack and acts as a
proton acceptor late in the reaction [4,5,34]. In addition, the HRD
aspartate mayhelp stabilize theinactive state through an interaction
with the unphosphorylated tyrosine in the activation loop [35].
Yeast carrying an aspartate to alanine substitution in cAMP-
dependent protein kinase (PKA) were nearly inviable and had
only 0.4% of the kinase activity of wild type [36]. Similarly,
phosphorylase kinase protein (Phk) with this mutation showed little
activity. Substitution with asparagine, the neutral amide derivative
of aspartate, eliminates charge without altering hydrogen-bonding
interactions that do not involve the carboxyl group. This mutation
strongly reduced Phk kinase activity, but not as strongly as alanine.
It caused a relatively small reduction in ATPase activity, suggesting
that aspartate is critical for phosphoryl transfer rather than ATP
hydrolysis [37]. The asparagine mutation in the tyrosine kinase Csk
also strongly reduces, but does not eliminate, kinase activity [38].
Mutation to glutamate alters structure and size but not charge; this
mutation also greatly reduces Csk activity [39].
Here we describe the effect of the HRD aspartate to asparagine
mutation on several well-characterized and quantifiable biological
processes in a living organism. Kinase activity of the src64
D404N
mutant is indistinguishable from that of src64
KO. src64
D404N
behaves like a null allele in both cytoskeletal processes examined.
Therefore, the src64
D404N mutation either eliminates kinase activity
or reduces it below the threshold required for function. However,
for fertility and embryonic viability, src64
D404N acts as a reduction-
Figure 3. Cellularization microfilament defects in src64 mutant embryos. Embryos are stained with antibody to myosin II heavy chain. (A)
Cross-sections showing the early cellularization front. Furrow canal depths are less uniform, producing a wavy and irregular cellularization fronti n
src64
D17, src64
H402L, src64
D404N and src64
KO mutant embryos. Scale bar, 50 mm. (B) Grazing section projections of early cellularization stage embryos
showing the microfilament network. Microfilament rings of src64
D17, src64
H402L, src64
D404N and src64
KO mutant embryos are irregular. Scale bar, 10 mm.
(C) Grazing section projections of late cellularization stage embryos showing microfilament rings. Microfilament rings of src64
D17, src64
H402L,
src64
D404N and src64
KO mutant embryos are irregular and less constricted than the microfilament rings of wild-type embryos and src64
R403C mutant
embryos. Scale bar, 10 mm. (D) Microfilament ring circularity during early cellularization. A, does not differ from +; AB, differs from + and src64
D17;B ,
does not differ from src64
D17 allele but differs from + (P,0.01); C, does not differ from src64
KO but differs from + (P,0.001) and src64
D17 (P,0.001).
Error bars are SEM. (E) Microfilament ring circularity during late cellularization. A, does not differ from +; B, does not differ from src64
D17 but differs
from + (P,0.05); C, does not differ from src64
KO but differs from + (P,0.001) and src64
D17 (P,0.001). Error bars are SEM.
doi:10.1371/journal.pone.0028100.g003
Figure 4. Tyrosine kinase activities of src64 HRD mutants.
Phosphotransfer was measured in cellularization-stage embryo extracts.
Src64-dependent phosphotransfer to a peptide substrate is shown.
src64
H402L, src64
D404N and src64
KO differ from wild type (p,0.01). Wild
type, src64
H402L and src64
R403C differ from src64
KO (p,0.01). Error bars
are SEM.
doi:10.1371/journal.pone.0028100.g004
Src64 HRD Mutants
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sufficient for some biological function. Together, these results are
consistent with in vitro studies of purified PKA, Phk and Csk
proteins showing that mutation to asparagine severely reduced,
but did not eliminate, kinase activity. Alternately, src64
D404N may
behave as a reduction-of-function mutation in fertility because
Src64 has a kinase-independent activity; however, kinase-dead
SFKs can titrate negative regulators and increase the activity of
other SFKs, arguing against this [40,41]. Although kinase-inactive
alleles of src have been reported to act as dominant-negative alleles
[42–44], we did not observe dominant negative activity of
src64
D404N. When over-expressed in the developing eye, kinase-
dead SFKs also do not act in a dominant negative manner [40].
src64
R403C mutation
RD kinases suchas SFKs have arginine in the catalytic loop HRD
motif and are only fully activated by phosphorylation of the
activation loop [45]. Transition to the fully active conformation is
salt-dependent and the HRD arginine has different charge-based
interactions in the active and inactive conformations, suggesting that
activation involves an electrostatic switch [46–50]. In the inactive
conformation, glutamate E327 (c-Src E310) is salt-bridged to either
the HRD arginine R403 (c-Src R385) or the activation loop arginine
R427 (c-Src R409) [48,49]. In the active conformation, the
phosphorylated tyrosine interacts with both R403 and R427, and
glutamate is salt-bridged to lysine K312 (c-Src K295), a critical
linkage in the fully active conformation [48,51–53]. The arginine
switch may be part of a sequential series of electrostatic switches that
drive conformation change [35,50]. These arginines are likely
partially redundant for phosphotyrosine coordination: the activation
loop arginine plays the major role in stabilizing both active and
inactive configurations in SFKs, whereas the HRD arginine plays
the major role in serine/threonine kinases [35,53,54]. The HRD
arginine may also stabilizethe DFGaspartateinthe active state [55].
Figure 5. Cytoskeletal defects of src64
D404N/src64
KO trans-heterozygotes. (A) src64
D404N/+, src64
D404N and src64
D404N/src64
KO egg chambers
stained with antibody to HTS. Ring canal diameters are not reduced in src64
D404N/+ egg chambers but are reduced in src64
D404N/src64
KO egg
chambers. Inset: ring canal of approximately mean diameter, reoriented so that diameter is projected along the vertical axis. Scale bar, 50 mm. (B)
Early cellularization stage embryos laid by src64
KO, src64
D404N and src64
D404N/src64
KO mothers. Embryos show non-uniform cellularization fronts. Scale
bar, 100 mm. (C) Grazing section projections of early cellularization stage embryos laid by src64
KO, src64
D404N and src64
D404N/src64
KO mothers showing
microfilament networks. Microfilament ring defects of maternally trans-heterozygous src64
D404N/src64
KO embryos are similar to those of src64
KO and
src64
D404N embryos. Embryos are stained with antibody to myosin II heavy chain. Scale bar, 10 mm. (D) Ring canal diameters. src64
D404N and
src64
D404N/src64
KO do not differ (p=0.35). Error bars are SEM. (E) Microfilament ring circularity during early cellularization. src64
D404N and src64
D404N/
src64
KO do not differ (p=0.52). Error bars are SEM.
doi:10.1371/journal.pone.0028100.g005
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kinase activity to 10.5% of wild-type activity, but viability is
unaffected [36]. In PhK, this mutation also reduces kinase activity
[37]. Kinase activity of the chicken c-Src mutant protein is 10%
for an exogenous substrate but 50% for autophosphorylation [56].
Mutation of the HRD arginine to cysteine has remarkably little
effect on Src64. Kinase activity was indistinguishable from wild
type, and there was no effect on microfilament contraction, ring
canal growth or hatching and only weak defects in egg production.
Our data do not support a major role for the HRD arginine in
stabilization of the active site or in an electrostatic switch for
activation, and are consistent with the activation loop arginine
being the critical arginine residue in tyrosine kinases. However, the
Src64 cysteine mutant has more kinase activity than the c-Src
alanine mutant, suggesting that cysteine may not abrogate
biochemical activity. The alanine side chain is short and aliphatic,
so it likely eliminates biochemical activity, whereas the polar
cysteine side chain may retain sufficient biochemical activity for
function. Alternately, src64
R403C may destabilize both the active
and inactive conformations by failing to interact with both
phospho-Y434 and E327, thus favoring the partially active
conformation that would produce a constant but low level of
activity.
src64
H402L mutation
The HRD histidine is, along with the HRD aspartate, one of ten
critical residues conserved amongst eukaryotic protein kinases and
eukaryotic protein kinase-like kinases in prokaryotes [57]. The
histidine peptide backbone hydrogen bonds to the C-terminal end
of the activation loop DFG motif and to the F-helix aspartate in
the kinase domain C-terminal lobe. The side chain has a
hydrophobic packing interaction with the DFG phenylalanine,
and hydrogen bonds to the N-terminal end of the DFG motif and
to the polypeptide backbone of the HRD aspartate. Thus, the
HRD histidine provides two critical links in the active kinase:
between the catalytic and activation loops in the active site, and
between the active site and the enzyme core [6]. The histidine side
chain is a component of the regulatory spine (R-spine), a stack of
amino acid side chains linked by hydrophobic interactions that
spans the fully active kinase domain [58,59]. The R-spine consists
of four residues: the catalytic loop HRD histidine H402 (c-Src
H384), the activation loop DFG phenylalanine F423 (c-Src F408),
a C-helix hydrophobic residue M331 (c-Src M317), and a b-4
strand leucine L342 (c-Src L328) [58–61]. The hydrogen bond
between the histidine polypeptide backbone and the F-helix
aspartate anchors the R-spine to the rigid F-helix. Together with
the catalytic spine (C-spine), another stack of hydrophobic residues
anchored to the F-helix, it connects the two lobes of the kinase
domain and stabilizes the active conformation [6,58,59,61].
The HRD histidine has not been investigated by in vitro
mutagenesis, but the other three R-spine residues have. Mutation
of the p38 MAP kinase DFG phenylalanine to alanine, arginine, or
glycine abrogated activity, whereas mutation to tyrosine reduced
kinase activity to 1% [55]. The mutant tyrosine side chain retained
its hydrophobic contact with histidine, suggesting that addition of
a polar hydroxyl group is sufficient to partially destabilize the R-
spine [55,62]. Mutation of either the DFG phenylalanine or the C-
helix methionine to glycine rendered the nonreceptor tyrosine
kinase Abl inactive, whereas mutation of the b-4 strand leucine
residue to glycine reduced kinase activity [60].
Here we describe the effect of an HRD histidine mutation on
the activity and function of a kinase in a living organism. The
src64
H402L mutation reduces kinase activity to 27% of wild-type
activity and produces moderate to weak, but significant, defects in
microfilament ring contraction and ring canal growth. Therefore,
a quarter of the wild-type level of Src64 activity is not sufficient for
normal cytoskeletal function in these processes. However,
substantial cytoskeletal function remains at this lower Src64
activity level. We postulate that the src64
H402L mutation alters
interactions within the active site without altering the global
conformation of the active kinase. The mutant leucine side chain is
unlikely to hydrogen bond with the polypeptide backbones of the
DFG aspartate and the HRD aspartate; loss of these active site
interactions likely causes the reduction in kinase activity and the
phenotypic defects. The hydrophobic interaction with the DFG
phenylalanine should be retained, so a stable R-spine should still
form. The hydrogen bond from the polypeptide backbone to the
F-helix aspartate should be retained, so the catalytic loop and the
R-spine should still be anchored to the F-helix, and thus linked to
the C-lobe and the C-spine. Likewise, the hydrogen bond from the
polypeptide backbone to the DFG motif is unlikely to be altered.
Therefore, several interactions between histidine and the activa-
tion loop should be retained. The phenotype of this mutant
suggests that the primary function of the HRD histidine may be to
assemble and stabilize the R-spine and anchor it to the F-helix,
and that its role in linking the catalytic loop to the activation loop
may be less important.
In summary, our data suggest that the catalytic loop HRD
amino acids have more complex roles in kinase activity and
activation than previously thought. In addition, we have developed
an experimental paradigm for a combined in vivo and in vitro
investigation of the roles of specific amino acids in Src64. By
making specific amino acid substitutions in a src64 transgene
expressed in src64
KO flies, this approach can be used to further
define the biochemical roles of the HRD histidine and arginine
amino acids in SFKs.
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